CARBO

France French Guiana Guadeloupe Martinique Réunion
|
2010-2023
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Infants (<1 year)
  • Adolescents (12-17 years)
  • Children (1-11 years)
  • Hospital
  • Outpatient clinic
  • Emergency department
  • Arbovirus
  • Chikungunya virus
  • Vector-borne
  • Dengue virus
  • Zika virus
  • West Nile virus
  • Japanese encephalitis virus
  • Arboviral disease
  • Vector-borne disease

CHIKGene

France Réunion
|
2005
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Community
  • Arbovirus
  • Chikungunya virus
  • Vector-borne
  • Arboviral disease
  • Vector-borne disease
  • Post-acute infection syndrome

REUNION Study

France Réunion
|
2022
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Community
  • Arbovirus
  • Chikungunya virus
  • Vector-borne
  • Arboviral disease
  • Vector-borne disease
  • Post-acute infection syndrome

Doran

The Netherlands Curaçao
|
2015
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Community
  • Arbovirus
  • Chikungunya virus
  • Vector-borne
  • Arboviral disease
  • Vector-borne disease
  • Post-acute infection syndrome

ChikRhuma15

France Réunion
|
2023-2025
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Community
  • Arbovirus
  • Chikungunya virus
  • Vector-borne
  • Arboviral disease
  • Vector-borne disease
  • Post-acute infection syndrome

HOT-LoCO

Sweden
|
2021-2024
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition
  • Non pharmacological intervention
  • Oxygen therapy

Prüßler

Germany
|
2023-2025
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition
  • Non pharmacological intervention
  • Immunoadsorption

PROLIFIC

Sweden
|
2023-2024
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition
  • Pharmacological intervention
  • Antivirals
  • Nirmatrelvir/Ritonavir

Cathomas

Switzerland
|
2024-2028
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition
  • Non pharmacological intervention
  • Rehabilitation
  • Neuromodulation

GAT

Germany
|
2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition
  • Non pharmacological intervention
  • Vocal-based therapy

STWandRVD

Italy
|
2023-2023
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Community
  • SARS-CoV-2
  • Post COVID-19 condition
  • Non pharmacological intervention
  • Hydrotherapy

Koczulla

Germany
|
2021-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition
  • Non pharmacological intervention
  • Neurostimulation